← Back to All Filings

Cytokinetics CEO Gifts 2,000 Shares of Company Stock

Low SignificanceNovember 5, 2025 at 4:32:50 PM EST

CYTOKINETICS INC

$CYTK4CIK: 0001061983

Subscribe to track CYTK

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Cytokinetics CEO Gifts 2,000 Shares of Company Stock

Company: CYTOKINETICS INC (CYTK) Form: 4 | Filed: 2025/11/05 Significance: Low

Insider: Blum Robert I Title: President & CEO | Relationship: Director, Officer

Transaction: • Type: Gift • Shares: 2,000 • Price: $0.00 • Value: $0 • Owned After: 356,108 (Directly)

Key Insight: This is a minor gift transaction by the CEO, representing a negligible percentage of shares outstanding and having no direct market value. Such transactions are typically for personal or estate planning and are not considered significant market signals.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: CYTOKINETICS INC (CYTK)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The President & CEO, Robert I. Blum, made a gift of 2,000 shares of common stock, a transaction with no monetary value and minimal impact on his overall holdings.
  • Market Impact: Neutral. This transaction is not expected to have any impact on the stock price or trading volume.

Company Information

FieldValue
CompanyCYTOKINETICS INC
Ticker SymbolCYTK
CIK0001061983
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameBlum Robert I
CIK0001288859
Title/PositionPresident & CEO
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-05
Transaction CodeG (Gift)
Security TypeCommon Stock
Shares Involved2,000
Price Per Share$0.00
Total Value$0
Shares Owned After356,108 (Directly)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted2,000
% of Shares Outstanding0.0017%
Post-Transaction Ownership360,274 shares (0.30% of outstanding, including indirect holdings)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Cytokinetics has a market capitalization of $7.61 billion. The transaction value is $0, making it immaterial.
  • Ownership Concentration: The 2,000 shares gifted represent a very small fraction of the CEO's total direct and indirect holdings of 360,274 shares. His ownership stake remains low at approximately 0.30%.
  • Transaction Significance: The transaction is a gift (Code G), which is a disposition of shares for no value. It constitutes a negligible 0.0017% of the total shares outstanding, categorizing its significance as Low.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Gift transactions are typically for personal financial or estate planning and do not reflect an insider's sentiment on the company's future performance. The size is insignificant relative to the company's market cap and public float.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to influence trading volume.
  • Sentiment Indicator: Neutral. The filing does not provide any bullish or bearish signals.

Additional Context

Transaction Notes

  • The filing indicates a disposition of 2,000 shares via a gift. The footnotes detail indirect holdings in two separate trusts for family members.
Topics:#SECFiling#InsiderTrading#CYTK#Cytokinetics#Form4#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.